Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoembolization”

520 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 520 results

Not applicableUnknownNCT00730860
What this trial is testing

Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE

Who this might be right for
Cancer of Liver
Southwest Hospital, China 140
Testing effectiveness (Phase 2)Ended earlyNCT01060423
What this trial is testing

TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hans-Joachim Schmoll, MD 8
Testing effectiveness (Phase 2)UnknownNCT00960518
What this trial is testing

TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatitis B VirusHepatocellular Carcinoma
Tongji University 216
Not applicableStudy completedNCT03474354
What this trial is testing

DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CancerChemoembolization
Malagari Katerina 50
Testing effectiveness (Phase 2)UnknownNCT05903456
What this trial is testing

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 20
Not applicableNot Yet RecruitingNCT07183566
What this trial is testing

CT Volume Measurement of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)CT
Assiut University 66
Large-scale testing (Phase 3)Study completedNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 479
Testing effectiveness (Phase 2)Study completedNCT00956930
What this trial is testing

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Who this might be right for
Liver Cancer
Northwestern University 45
Testing effectiveness (Phase 2)Study completedNCT03397654
What this trial is testing

Study of Pembrolizumab Following TACE in Primary Liver Carcinoma

Who this might be right for
Primary Liver Carcinoma
Imperial College London 26
Large-scale testing (Phase 3)UnknownNCT00501813
What this trial is testing

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 160
Large-scale testing (Phase 3)Looking for participantsNCT06485466
What this trial is testing

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaTransarterial ChemoembolizationCamrelizumab+1 more
Guohui Xu 101
Not applicableUnknownNCT05631613
What this trial is testing

Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 40
Large-scale testing (Phase 3)Study completedNCT01259414
What this trial is testing

Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 812
Large-scale testing (Phase 3)Ended earlyNCT01465464
What this trial is testing

Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Taiho Pharmaceutical Co., Ltd. 888
Testing effectiveness (Phase 2)UnknownNCT04652492
What this trial is testing

Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728633
What this trial is testing

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8
Thomas Jefferson University 28
Not applicableLooking for participantsNCT04996914
What this trial is testing

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
RWTH Aachen University 30
Testing effectiveness (Phase 2)WithdrawnNCT03782831
What this trial is testing

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Not applicableUnknownNCT03285867
What this trial is testing

Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Failure
Nanfang Hospital, Southern Medical University 200
Large-scale testing (Phase 3)UnknownNCT03939845
What this trial is testing

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 180
Load More Results